phase 2
Bepirovirsen Reduces HBV Proteins in Phase 2B Trial
Bepirovirsen appears most effective in reducing hepatitis B viral levels at a dose of 300 mg for 24 weeks, ...
MAY 19, 2023
It’s Just a Phase: Filgotinib for Moderately to Severely Active Ulcerative Colitis
Gastroenterology & Endoscopy News generally avoids coverage of phase 2 trials. After all, preliminary results ...
SEPTEMBER 3, 2021
Load more